BARCLAYS PLC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 90 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$66
-52.2%
17,777
-13.1%
0.00%
Q2 2023$138
-40.5%
20,460
-42.8%
0.00%
Q1 2023$232
+31.1%
35,782
+71.9%
0.00%
Q4 2022$177
-99.8%
20,810
+4.1%
0.00%
Q3 2022$106,000
+19.1%
19,985
-4.4%
0.00%
Q2 2022$89,000
+48.3%
20,897
+22.2%
0.00%
Q1 2022$60,00017,1050.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,618,036$80,871,0003.02%
Orbimed Advisors 8,740,887$270,006,0002.73%
Boxer Capital, LLC 1,675,377$51,752,0001.83%
Endurant Capital Management LP 139,124$4,298,0001.18%
Nantahala Capital Management 1,266,266$39,115,0001.11%
COMMODORE CAPITAL LP 97,143$3,001,0001.05%
Ally Bridge Group (NY) LLC 128,572$3,972,0000.99%
RA Capital Management 1,742,186$53,816,0000.86%
HighVista Strategies LLC 25,906$800,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 173,891$5,371,0000.36%
View complete list of SILVERBACK THERAPEUTICS INC shareholders